To amend title III of the Public Health Service Act to ensure that Federally-qualified health centers are not required to pay more than the 340B ceiling price for covered outpatient drugs at the time of purchase.
Last action: 2-5-2026
Version: 2026012515
Current status: Referred to the House Committee on Energy and Commerce.